📈 69% of S&P 500 stocks beating the index - a historic record! Pick the best ones with AI.See top stocks

Vyant Bio Inc (VYNT)

OTC Markets
Currency in USD
Disclaimer
0.194
0.000(0.00%)
Delayed Data
VYNT Scorecard
Full Analysis
Stock generally trades with low price volatility
Fair Value
Day's Range
0.1750.200
52 wk Range
0.1411.040
Prev. Close
0.18
Open
0.18
Day's Range
0.175-0.2
52 wk Range
0.141-1.04
Volume
0
Average Volume (3m)
19,433
1-Year Change
12.79%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
VYNT Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins
Show more

Vyant Bio Company Profile

Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company’s central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome (Rett), CDKL5 deficiency disorders (CDD,) and familial Parkinson’s disease (PD). The company is based in Cherry Hill, New Jersey.

Compare VYNT to Peers and Sector

Metrics to compare
VYNT
Peers
Sector
Relationship
P/E Ratio
0.0x−0.4x−0.6x
PEG Ratio
0.000.000.00
Price/Book
0.0x0.6x2.6x
Price / LTM Sales
0.0x2.9x3.2x
Upside (Analyst Target)
0.0%0.0%44.4%
Fair Value Upside
Unlock29.0%6.2%Unlock
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.